PSK may suppress CD57+ T cells to improve survival of advanced gastric cancer patients

International Journal of Clinical Oncology

Volumn 15, Issue 2, 2010, Pages 145-152

  Akagi, Junji ^a   Baba, Hideo ^b  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

CD57+ T cells; Gastric cancer; Natural killer T cells; Prognosis; PSK

Indexed keywords

CD56 ANTIGEN; CD57 ANTIGEN; KRESTIN; UFT;

ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL INDICATOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MALE; MONOTHERAPY; NATURAL KILLER CELL; NATURAL KILLER T CELL; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; TH1 CELL; TH2 CELL; TREATMENT DURATION; TUMOR IMMUNITY; TUMOR IMMUNOLOGY;

AGED; ANTIGENS, CD57; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DRUG COMBINATIONS; FEMALE; FUNGAL PROTEINS; GASTRECTOMY; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYSACCHARIDES; STOMACH NEOPLASMS; T-LYMPHOCYTE SUBSETS; TEGAFUR; TIME FACTORS; TREATMENT OUTCOME; URACIL;

EID: 77950922342     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-010-0033-1     Document Type: Article

References (47)

1. S Tsukagoshi Y Hashimoto G Fujii, et al. 1984 Krestin (PSK) Cancer Treat Rev 11 131 155 10.1016/0305-7372(84)90005-7 1:STN:280:DyaL2M%2FkvVyitA%3D%3D 6238674 (Pubitemid 16004444)
2. H Kobayashi K Matsunaga Y Oguchi 1995 Anti-metastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview Cancer Epidemiol Biomarkers Prev 4 275 281 1:CAS:528:DyaK2MXlslCqs74%3D 7606203
3. H Nakazato A Koike S Saji, et al. 1994 Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer Lancet 343 1122 1126 10.1016/S0140-6736(94)90233-X 1:STN:280:DyaK2c3jvFShtQ%3D%3D 7910230 (Pubitemid 24142032)
4. T Mitomi S Tsuchiya N Iijima, et al. 1992 Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer Dis Colon Rectum 35 123 130 10.1007/BF02050666 1:STN:280:DyaK387js12mtw%3D%3D 1735313
5. S Ohwada T Ikeya T Yokomori, et al. 2004 Adjuvant immunochemotherapy with oral tegafur/uracil plus PSK in patients with stage II or III colorectal cancer: a randomized controlled study Br J Cancer 90 1003 1010 10.1038/sj.bjc.6601619 1:CAS:528:DC%2BD2cXhslWrsL4%3D 14997197 (Pubitemid 38495819)
6. K Hirose CO Zachariae JJ Oppenheim, et al. 1990 Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells Lymphokine Res 9 475 483 1:CAS:528: DyaK3cXmt1Cgs70%3D 2090874
7. Y Abe M Miyake A Horiuchi, et al. 1990 Induction of cytokines by polysaccharide K in the peripheral blood mononuclear cell culture J Clin Exp Med 152 617 1:CAS:528:DyaK3cXktVShsLc%3D
8. M Kanazawa Y Mori K Yoshihara, et al. 2004 Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocyte Immunol Lett 91 229 238 10.1016/j.imlet.2003.12.007 1:CAS:528: DC%2BD2cXhs12nu70%3D 15019294 (Pubitemid 38296383)
9. M Harada K Matsunaga Y Oguchi, et al. 1995 The involvement of transforming growth factor beta in the impaired antitumor T cell response at the gut-associated lymphoid tissue (GALT) Cancer Res 55 6146 6151 1:CAS:528:DyaK2MXhtVShtLzK 8521406
10. TC Van der Pouw Kraan LC Beoije RJ Smeenk, et al. 1995 Prostaglandin E2 is a potent inhibitor of human interleukin 12 production J Exp Med 181 775 779 10.1084/jem.181.2.775 7836930
11. JL Matsuda L Gapin N Fazilleau, et al. 2001 Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor repertoire and small clone size Proc Natl Acad Sci USA 98 12636 12641 10.1073/pnas.221445298 1:CAS:528:DC%2BD3MXotFaiu7w%3D 11592984 (Pubitemid 33019998)
12. M Terabe JA Berzofsky 2008 The role of NKT cells in tumor immunity Adv Cancer Res 101 277 348 10.1016/S0065-230X(08)00408-9 1:CAS:528: DC%2BD1MXht1CrtL%2FP 19055947
13. + T cells in patients with malignancy Clin Exp Immunol 97 522 527 1:STN:280:DyaK2czmtl2hsw%3D%3D 7521809
14. + T cells which increase at tumour sites in patients with colorectal cancer Clin Exp Immunol 102 159 166 1:STN:280:DyaK28%2Fgtl2ltw%3D%3D 7554383
15. S Koyama T Ebihara K Fukao 1992 Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma J Cancer Res Clin Oncol 118 609 614 10.1007/BF01211806 1:STN:280:DyaK38zovVagtA%3D%3D 1355484
16. N Karimine S Nanbara S Arinaga, et al. 1994 Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients J Surg Oncol 55 179 185 10.1002/jso.2930550310 1:STN:280:DyaK2c3jtFOktQ%3D%3D 8176929 (Pubitemid 24096520)
17. + T cells subset inhibits antigen-specific T-cell responses and prevents colitis Nature (Lond) 389 737 742 10.1038/39614 1:CAS:528:DyaK2sXmvVSgtb0%3D (Pubitemid 27458961)
18. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J Exp Med 188 287 296 10.1084/jem.188.2.287 (Pubitemid 28357757)
19. + immunoregulatory T cells is antigen nonspecific J Immunol 164 183 190
20. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J Exp Med 192 303 310 10.1084/jem.192.2.303 1:CAS:528:DC%2BD3cXkvFGiu7c%3D 10899917 (Pubitemid 30470313)
21. S Sakaguchi 2000 Regulatory T cells: key controllers of immunologic self-tolerance Cell 101 455 458 10.1016/S0092-8674(00)80856-9 1:CAS:528:DC%2BD3cXjvFWntL4%3D 10850488
22. + suppressor T cells J Exp Med 193 F41 F46 10.1084/jem.193.11.F41 1:CAS:528:DC%2BD3MXktFyitbc%3D 11390442
23. + regulatory T cells suppress NKT cell functions Cancer Res 63 4516 4520 1:CAS:528:DC%2BD3sXmtFers78%3D 12907625
24. F Ichihara K Kono A Takahashi, et al. 2003 Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patient with gastric and esophageal cancers Clin Cancer Res 9 4404 4408 14555512 (Pubitemid 37248397)
25. AM Wolf D Wolf M Steurer, et al. 2003 Increase of regulatory T cells in the peripheral blood of cancer patients Clin Cancer Res 9 606 612 12576425
26. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression Cancer (Phila) 98 1089 1099 10.1002/cncr.11618 (Pubitemid 37022112)
27. LJ Picker MK Singh Z Zdraveski, et al. 1995 Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry Blood 86 1408 1419 1:CAS:528:DyaK2MXnsVCltrw%3D 7632949
28. + T lymphocytes in the peripheral blood of advanced gastric cancer patients. Int J Clin Oncol (in press)
29. K Oba S Teramukai M Kobayashi, et al. 2007 Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer Cancer Immunol Immunother 56 905 911 10.1007/s00262-006-0248-1 1:CAS:528:DC%2BD2sXjsFyhtbg%3D 17106715 (Pubitemid 46729147)
30. - natural killer T cells specific for MUC1 mucin Cancer Res 64 1171 1180 10.1158/0008-5472.CAN- 3254-2 1:CAS:528:DC%2BD2cXhtFCgt74%3D 14871854 (Pubitemid 38176926)
31. CN Baxevanis AD Gritzapis OE Tsitsilois, et al. 2002 HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes Int J Cancer 20 864 872 10.1002/ijc.10251 (Pubitemid 34286682)
32. + lymphocytes and T cell dysfunction in recipients of bone marrow transplantation Clin Exp Immunol 82 145 150 1:STN:280:DyaK3M%2FgsV2jsA%3D%3D 1698579
33. W Hilbe W Eisterer C Schmid 1994 Bone marrow lymphocytes subsets in myelodysplastic syndromes J Clin Pathol 47 505 507 10.1136/jcp.47.6.505 1:STN:280:DyaK2czkt1Cqtw%3D%3D 8063930
34. + T cells with restricted T-cell receptor chain variability after bone marrow transplantation Blood 83 587 595 1:STN:280:DyaK2c7hsV2nsQ%3D%3D 7506956 (Pubitemid 24030589)
35. I Fregona RD Guttmann R Jean 1985 HNK-1 + (Leu-7) and other lymphocyte subsets in long-term survivors with renal allotransplants Transplantation 39 25 29 1:STN:280:DyaL2M%2FptFGjtg%3D%3D 3880961 (Pubitemid 15188790)
36. + T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti-inflammatory role Clin Exp Immunol 111 345 352 10.1046/j.1365-2249.1998.00511.x 1:STN:280:DyaK1c7ksFyjtQ%3D%3D 9486402 (Pubitemid 28088316)
37. + lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease Arthritis Rheum 36 608 612 10.1002/art.1780360506 7683880 (Pubitemid 23149907)
38. + T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection Blood 79 1746 1753 1:STN:280:DyaK383hs1SrsQ%3D%3D 1373086
39. + T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients Eur J Immunol 24 2882 2888 10.1002/eji.1830241145 1:CAS:528:DyaK2MXitVCgs78%3D 7525310 (Pubitemid 24342211)
40. + lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis Blood 77 2237 2241 1:STN:280:DyaK3M3jtVenuw%3D%3D 1709378
41. + T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer Oncol Rep 20 2443 2448
42. + lymphocyte subset in interferon therapy of patients with renal cell carcinoma Anticancer Res 22 3679 3684 12552976
43. + T cells J Immunol 178 5010 5017 1:CAS:528:DC%2BD2sXjslWjsbg%3D 17404283
44. T Alvaro M Lejeune MT Salvado, et al. 2006 Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma J Clin Oncol 24 5350 5357 10.1200/JCO.2006.06.4766 17135637 (Pubitemid 46623165)
45. + T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity Int Immunol 10 311 323 10.1093/intimm/10.3. 311 1:CAS:528:DyaK1cXisVyjsLk%3D 9576619 (Pubitemid 28132717)
46. +/CD57 cells and apoptosis suppress T-cell functions in multiple myeloma Br J Haematol 100 469 477 10.1046/j.1365-2141.1998.00589.x 1:STN:280:DyaK1c7mtlWmtA%3D%3D 9504628 (Pubitemid 28270481)
47. - compartment Blood 98 2817 2827 10.1182/blood.V98.9.2817 1:CAS:528: DC%2BD3MXotVegtrw%3D 11675356